Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: A phase II Hoosier Oncology Group study

Urologic Oncology: Seminars and Original Investigations

Volumn 23, Issue 5, 2005, Pages 382-

  Li, J ^a   Juliar, B ^a   Yiannoutsos, C ^a   Ansari, R ^a   Fox, E ^a   Fisch, M J ^a   Einhorn, L H ^a   Sweeney, C J ^a   Trump, Donald L ^b  

^a INDIANA UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; PACLITAXEL;

CLINICAL ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; GRANULOCYTOPENIA; HUMAN; LOW DRUG DOSE; LUNG TOXICITY; MULTICENTER STUDY; NEUROPATHY; NOTE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

EID: 24344451238     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2005.06.011     Document Type: Short Survey

References (0)